1
|
García-García AL, Hernández D, Santana-Mayor Á, Jiménez-Arias D, Boto A. TBS-pyrrole as an "universal" reference to quantify artemisinin and structurally-diverse natural products in plants extracts by NMR. FRONTIERS IN PLANT SCIENCE 2023; 14:1255512. [PMID: 37841619 PMCID: PMC10570554 DOI: 10.3389/fpls.2023.1255512] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 07/17/2023] [Accepted: 08/31/2023] [Indexed: 10/17/2023]
Abstract
The commercial production of artemisinin and other valuable bioactive natural products depends on their plant sources, which may provide variable amounts of the compound depending on plant variety, the period of the year, abiotic stress and other factors. Therefore, it requires a method for large-scale, low-cost natural product quantification. The standard HPLC and UHPLC methods are accurate but the analysis are costly and require different optimization for structurally-diverse products. An alternative method using NMR with TBS-pyrrole as a novel "universal" reference affords a simple, fast method to quantify many different products. The method is shown with antimalarial artemisinin, whose yield using conventional and novel extraction procedures was determined by standard UHPLC-MS procedures and by our NMR protocol, with similar quantification results. The novel reference compound does not interfere with artemisinin or extract signals, only needs a small amount of the extract, is accurate and operationally simple, and a large volume of samples can be processed in little time. Moreover, bioactive terpenes, steroids, alkaloids, aromatic compounds, and quinones, among others, were quantified in a model vegetal extract with this "universal" reference with excellent accuracy.
Collapse
Affiliation(s)
- Ana L. García-García
- Grupo de Síntesis de Fármacos y Compuestos Bioactivos, Instituto de Productos Naturales y Agrobiología del Consejo Superior de Investigaciones Científicas (CSIC), La Laguna, Spain
- Programa de Doctorado de Química e Ingeniería Química, Universidad de La Laguna, San Cristóbal de La Laguna, Spain
| | - Dácil Hernández
- Grupo de Síntesis de Fármacos y Compuestos Bioactivos, Instituto de Productos Naturales y Agrobiología del Consejo Superior de Investigaciones Científicas (CSIC), La Laguna, Spain
| | - Álvaro Santana-Mayor
- Fundación Canaria General de la Universidad de La Laguna, Edificio Servicios Generales de Apoyo a la Investigación (SEGAI), San Cristóbal de La Laguna, Spain
| | - David Jiménez-Arias
- Isoplexis-Centro de Agricultura Sustentável e Tecnologia Alimentar, Universidade da Madeira, Funchal, Portugal
- Instituto Canario de Investigaciones Agrarias, La Laguna, Spain
| | - Alicia Boto
- Grupo de Síntesis de Fármacos y Compuestos Bioactivos, Instituto de Productos Naturales y Agrobiología del Consejo Superior de Investigaciones Científicas (CSIC), La Laguna, Spain
| |
Collapse
|
2
|
Abdelrahim M, Esmail A, Al Saadi N, Zsigmond E, Al Najjar E, Bugazia D, Al-Rawi H, Alsaadi A, Kaseb AO. Thymoquinone's Antiviral Effects: It is Time to be Proven in the Covid-19 Pandemic Era and its Omicron Variant Surge. Front Pharmacol 2022; 13:848676. [PMID: 35462919 PMCID: PMC9022724 DOI: 10.3389/fphar.2022.848676] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2022] [Accepted: 03/17/2022] [Indexed: 12/15/2022] Open
Abstract
The COVID-19 pandemic has impacted every country in the world. With more than 400 million cases and more than 5.5 million deaths. The FDA either approved or authorized the emergency use for three vaccines against COVID-19. The treatment options of COVID-19 are very limited. Multiple complementary and alternative medicine modalities were suggested to be efficacious in the treatment of COVID-19 such as Thymoquinone. The effects of Thymoquinone have been examined and multiple studies indicate a promising beneficial effect. However, the current body of research is limited in terms of its scope, quality, and quantity. While higher-quality studies are required, physicians do not routinely recommend the use of marketed supplements of natural products, including Thymoquinone for COVID-19. Given the numerous suggested positive effects of Thymoquinone, including anti-inflammatory and antimicrobial properties, additional research is required to confirm or refute these promising benefits. Complementary and alternative medicine is an area that requires additional evidence-based practice and research to confirm effects observed in clinical practice.
Collapse
Affiliation(s)
- Maen Abdelrahim
- Houston Methodist Cancer Center, Houston Methodist Hospital, Houston, TX, United States.,Cockrell Center for Advanced Therapeutic Phase I Program, Houston Methodist Research Institute, Houston, TX, United States.,Weill Cornell Medical College, Institute of Academic Medicine, Houston, TX, United States
| | - Abdullah Esmail
- Houston Methodist Cancer Center, Houston Methodist Hospital, Houston, TX, United States.,Houston Methodist Research Institute, Houston, TX, United States.,Faculty of Medicine and Health Sciences, University of Science and Technology, Sanaa, Yemen
| | - Noor Al Saadi
- Faculty of Medicine, Xavier University School of Medicine Aruba, Oranjestad, Aruba
| | - Eva Zsigmond
- Houston Methodist Cancer Center, Houston Methodist Hospital, Houston, TX, United States
| | - Ebtesam Al Najjar
- Faculty of Medicine and Health Sciences, University of Science and Technology, Sanaa, Yemen
| | - Doaa Bugazia
- Faculty of Medicine, University of Tripoli, Tripoli, Libya
| | - Hadeel Al-Rawi
- Faculty of Medicine, University of Jordan, Amman, Jordan
| | - Ayat Alsaadi
- Department of Biology and Chemistry, Buffalo State College, Buffalo, NY, United States
| | - Ahmed O Kaseb
- Department of Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
| |
Collapse
|